July 2020 Briefing - Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for July 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Telemedicine Use Explodes During COVID-19 Pandemic
FRIDAY, July 31, 2020 (HealthDay News) -- The emergence of telemedicine has accelerated during the coronavirus pandemic. HD Live! sat down with Rujuta Saksena, M.D., an oncologist at Overlook Medical Center in Summit, New Jersey, and Ateev Mehrotra, M.D., associate professor of health care policy at Harvard Medical School in Boston, to discuss the future of telemedicine and its impact on health care.
Inflammation Tied to Thyroid Dysfunction With Psoriasis
FRIDAY, July 31, 2020 (HealthDay News) -- Thyroid dysfunction in patients with psoriasis may be associated with inflammation caused by psoriasis, according to a study published online June 22 in the Journal of Dermatology.
Sex Differences in Income Vary With Proportion of Male Doctors
FRIDAY, July 31, 2020 (HealthDay News) -- For surgical and nonsurgical specialists, sex differences in income vary with the proportion of male physicians in a practice, according to a study published online July 30 in The BMJ.
More Diabetic Foot Amputations Seen During COVID-19 Lockdown
WEDNESDAY, July 29, 2020 (HealthDay News) -- Patients with diabetes admitted to a tertiary care center for diabetic foot ulceration (DFU) during the COVID-19 lockdown in Italy had a more than threefold risk for amputation versus patients seen in 2019, according to a study published online July 23 in Diabetes Care.
Cancer-Related Encounters Down Since Start of COVID-19
WEDNESDAY, July 29, 2020 (HealthDay News) -- There has been a decrease in cancer-related encounters and in cancer screening since the start of the COVID-19 pandemic, according to a study published online July 27 in JCO: Clinical Cancer Informatics.
CDC Guidance Issued for Testing, Management of HCP Exposed to Hep C
FRIDAY, July 24, 2020 (HealthDay News) -- In a U.S. Centers for Disease Control and Prevention guidance report, published in the July 24 issue of Morbidity and Mortality Weekly Report, recommendations are presented for testing and clinical management of health care personnel (HCP) exposed to the hepatitis C virus (HCV).
Financial Health of Hospitals 'Dire' Due to COVID-19
THURSDAY, July 23, 2020 (HealthDay News) -- COVID-19 continues to cause financial peril for U.S. hospitals, according to a report released by the American Hospital Association (AHA).
Pembrolizumab Use Supported in Advanced Melanoma
WEDNESDAY, July 22, 2020 (HealthDay News) -- Use of pembrolizumab is supported among patients with advanced melanoma, regardless of BRAF V600E/K mutation status or prior receipt of a BRAF inhibitor (BRAFi) with or without MEK inhibitor (MEKi) therapy, according to a study published online July 20 in JAMA Oncology.
Parents Make Some Common Sunscreen Mistakes
TUESDAY, July 21, 2020 (HealthDay News) -- Some parents may not be adequately protecting their children from the sun, according to a new C.S. Mott Children's Hospital national poll from the University of Michigan in Ann Arbor.
Physical Distancing Interventions Cut Incidence of COVID-19
THURSDAY, July 16, 2020 (HealthDay News) -- Physical distancing interventions are associated with a reduced incidence of COVID-19 globally, according to a study published online July 15 in The BMJ.
Roflumilast Cream Promising for Chronic Plaque Psoriasis
WEDNESDAY, July 15, 2020 (HealthDay News) -- Roflumilast cream is superior to placebo vehicle cream for reducing psoriasis severity, according to a study published in the July 16 issue of the New England Journal of Medicine.
Global Population Anticipated to Peak in 2064
WEDNESDAY, July 15, 2020 (HealthDay News) -- The global population is anticipated to peak in 2064 and then decline to year 2100, according to a study published online July 14 in The Lancet.
Layoffs Cost 5.4 Million Americans Their Health Insurance
TUESDAY, July 14, 2020 (HealthDay News) -- About 5.4 million Americans lost their health insurance after being laid off between February and May due to the COVID-19 pandemic, a new study shows.
Adherence to Prophylaxis for EGFRi-Linked Rash Beneficial
MONDAY, July 13, 2020 (HealthDay News) -- Increasing adherence to evidence-based prophylaxis protocols for epidermal growth factor receptor inhibitor (EGFRi)-associated rash can reduce interventions and toxicity-associated chemotherapy interruptions, according to a study published online July 1 in JAMA Dermatology.
S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants
MONDAY, July 13, 2020 (HealthDay News) -- Skin colonization by Staphylococcus aureus is associated with the risk for developing atopic dermatitis (AD), and infants who do not develop AD primarily exhibit acquisition of dysfunctional mutations in the S. aureus quorum-sensing system, according to a study published in the July 8 issue of Science Translational Medicine.
Nemolizumab Beats Placebo for Reduction of Pruritus in Eczema
THURSDAY, July 9, 2020 (HealthDay News) -- For patients with atopic dermatitis and moderate-to-severe pruritus, nemolizumab results in a greater reduction in pruritus than placebo, according to a study published in the July 9 issue of the New England Journal of Medicine.
Electronic Health Records Fail to Detect Many Medication Errors
THURSDAY, July 9, 2020 (HealthDay News) -- There is wide variation in the safety performance of electronic health record (EHR) systems used in U.S. hospitals, according to a study recently published in JAMA Network Open.
American Cancer Society Updates HPV Vaccination Guidelines
WEDNESDAY, July 8, 2020 (HealthDay News) -- The American Cancer Society has updated guidelines on human papillomavirus (HPV) vaccination, emphasizing that vaccination should be routinely offered at age 9 to 12 years; the updated recommendations were published online July 8 in CA: A Cancer Journal for Clinicians.
Oral Corticosteroid Bursts Carry Risk for Severe Adverse Events
TUESDAY, July 7, 2020 (HealthDay News) -- Prescriptions for oral steroid bursts are associated with a 1.8- to 2.4-fold increased risk for severe adverse events within the first month after initiation of drug therapy, according to a study published online July 7 in the Annals of Internal Medicine.
Chilblains in Recent Case Series Not Tied to COVID-19 Infection
TUESDAY, July 7, 2020 (HealthDay News) -- In a case series of 31 patients, published online June 25 in JAMA Dermatology, chilblains did not appear to be directly associated with COVID-19.
Roughly 2 Million Americans Buy Prescriptions From Outside the Country
THURSDAY, July 2, 2020 (HealthDay News) -- An estimated 1.5 percent of American adults purchase prescription medication from outside of the United States to save money, according to a study published online June 24 in JAMA Network Open.